Common use of DUTIES/RESPONSIBILITIES OF PARTIES Clause in Contracts

DUTIES/RESPONSIBILITIES OF PARTIES. The DPHHS will reimburse Corrections for chlamydia (CT), Gonorrhea (GC) and Syphilis testing and treatment. Both parties understand the CT/GC testing reimbursement program is limited to clients who are uninsured or underinsured. The clients must meet the following criteria to be eligible for reimbursement: adolescents/young adults, pregnant women, men who have sex with men, or a named partner/contact of a positive case. The criteria for reimbursement does not limit the Department of Corrections’ ability to establish individuals as 340B eligible patients through receiving an STD-related service that is in line with the intent of the STD Prevention grant to identify, treat, and control STDs. As of the date of execution of the MOU, the Centers for Disease Detection (CDD) lab in San Antonio, Texas, is offering a combo test (CT/GC) for $9.05 and syphilis test for $5.99, and provides an electronic interface allowing for immediate test results, inventory control, the ability to document clients meeting testing criteria and access to data/reports. Using CDD is beneficial to the STD program due to the universal electronic interface which will provide necessary data directly to the STD Program for CDC- reporting purposes. DPHHS has not mandated the use of Centers for Disease Detection (CDD) laboratory; however, the DPHHS will only reimburse the Corrections $100.00 per year for chlamydia, gonorrhea, and syphilis testing and treatment. Testing will be reimbursed at the CDD rate of $9.05 for CT/GC and $5.99 for DocuSign Envelope ID: D483B9A5-422F-444B-AB47-5523E01FE890 DocuSign Envelope ID: 867C628F-A81B-457E-B921-1A6DD1BBC465

DUTIES/RESPONSIBILITIES OF PARTIES. The DPHHS will reimburse Corrections for chlamydia (CT), Gonorrhea (GC) and Syphilis testing and treatment. Both parties understand the CT/GC testing reimbursement program is limited to clients who are uninsured or underinsured. The clients must meet the following criteria to be eligible for reimbursement: adolescents/young adults, pregnant women, men who have sex with men, or a named partner/contact of a positive case. The criteria for reimbursement does not limit the Department of Corrections’ ability to establish individuals as 340B eligible patients through receiving an STD-related service that is in line with the intent of the STD Prevention grant to identify, treat, and control STDs. As of the date of execution of the MOU, the Centers for Disease Detection (CDD) lab in San Antonio, Texas, is offering a combo test (CT/GC) for $9.05 and syphilis test for $5.99, and provides an electronic interface allowing for immediate test results, inventory control, the ability to document clients meeting testing criteria and access to data/reports. Using CDD is beneficial to the STD program due to the universal electronic interface which will provide necessary data directly to the STD Program for CDC- reporting purposes. DPHHS has not mandated the use of Centers for Disease Detection (CDD) laboratory; however, the DPHHS will only reimburse the Corrections $100.00 per year for chlamydia, gonorrhea, and syphilis testing and treatment. Testing will be reimbursed at the CDD rate of $9.05 for CT/GC and $5.99 for DocuSign Envelope ID: D483B9A5-422F-444B-AB47-5523E01FE890 DocuSign Envelope ID: 867C628F-A81B-457E-B921-1A6DD1BBC465syphilis. For testing and reimbursement, Corrections must submit the Formstack invoice electronically and keep all supporting documentation on file for audit purposes. Corrections must maintain documentation locally regarding reasons for testing. This agreement is not a guarantee of funds, and DPHHS duties and responsibilities are limited to the availability of funds. DPHHS will be able to fund STD testing and treatment until funds are depleted. If that occurs before the end of a calendar year, Corrections will be notified. Corrections must follow CDC’s STD Treatment Guidelines for treatment of chlamydia, gonorrhea, and syphilis.